Evidence map›Paper›PMID 41869021›Full record

ReviewSchizophrenia research. Cognition2026

Autistic symptomatology within the schizophrenia spectrum disorders: A narrative review of cognitive and social correlates and treatment implications.

Hiroshi Komatsu, Goh Onoguchi, Yutaro Sato, Yusuke Utsumi, Masato Takahama, Kaori Sora, Yoshiaki Shiozawa, Yuji Onouchi, Takashi Ono, Nobuhisa Kanahara and 1 more

Abstract readReview
In one paragraph

Review in Schizophrenia research. Cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hiroshi KomatsuDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Goh OnoguchiDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Yutaro SatoDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Yusuke UtsumiDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Masato TakahamaTohoku Bunka Gakuen University, Sendai, 980-8574, Miyagi, Japan.
Kaori SoraDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Yoshiaki ShiozawaDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Yuji OnouchiDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.
Takashi OnoMiyagi Psychiatric Center, Natori, 981-1231, Miyagi, Japan.
Nobuhisa KanaharaDivision of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, 260-8670, Japan.
Hiroaki TomitaDepartment of Psychiatry, Tohoku University Hospital, Sendai, 980-8574, Miyagi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Schizophrenia and autism spectrum disorder (ASD) are classified as distinct disorders; however, growing evidence suggests that they share genetic, neurobiological, and symptomatic features. Individuals with ASD have a higher risk of developing schizophrenia, and autistic symptoms frequently co-occur with schizophrenia spectrum disorder (SSD). Recently, a growing number of studies have been focusing on the association between autistic symptoms and clinical outcomes in patients with SSD, shifting the focus from categorical distinctions or overlaps between ASD and SSD to dimensional approaches. This narrative review examines the role of autistic symptoms in individuals with SSD, focusing on cognitive function, social functioning, psychosocial outcomes, neuroimaging findings, and treatment responsiveness. Methods: A literature search was conducted using PubMed, Web of Science, and Scopus to identify studies on autistic symptoms in SSD. Results: Autistic symptoms in SSD are associated with cognitive deficits, and social functioning tends to be impaired in individuals with stronger autistic symptoms. Limited studies have suggested that autistic symptoms may influence treatment response in schizophrenia. Conclusions: We propose that autistic symptoms in SSD may manifest in three distinct patterns based on the severity of pre-onset autistic symptoms. Future studies should clarify whether these symptoms represent a distinct SSD subtype or share common neurodevelopmental mechanisms with ASD.

Indexed as

Autistic symptomsCognitive functionSchizophrenia spectrum disorderSocial functionVariations in treatment response

Identifiers

PMID41869021
PMCPMC13000527

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.